Find an Article

Filter articles

Applied Filters

Showing 111 to 120 of 273 results

Doubling up: biotech patent examination in Brazil

Brazil25-10-2016Marcelo Oliveira de Souza and Antonio Alexandre Moura dos Santos

Two bodies are responsible for examining biotech patent applications in Brazil, but this approach causes problems, as Marcelo Oliveira de Souza and Antonio Alexandre Moura dos Santos of Di Blasi, Parente & Associados report.

IP service providers: a more cost-effective solution post M&A?

International18-10-2016Melissa Pillote

With specialist IP providers offering post-M&A services at lower cost than traditional law firms, have clients been overspending in the past? Melissa Pillote on behalf of Dennemeyer reports.

Russian patent law: Natural selection

Russia17-10-2016Valery Djermakian

There is some debate among Russian legal professionals about whether “selection inventions” are considered patentable, but the answer seems clear, says Valery Djermakian of Gorodissky & Partners.

Technology transfer: A smart way of working

International14-10-2016Montserrat González-Álvarez

‘Technological intelligence’ is very important for extracting maximum value from technology transfer deals, and life sciences companies should use it to their advantage, says Montserrat González-Álvarez of Leyva, Montenegro, Trigueros Abogados.

Brazilian biodiversity: Levelling the genetic resources playing field

Brazil13-10-2016Gabriel Di Blasi and Eduardo Emrich

New legislation in Brazil aims to create a balance between using genetic resources for scientific advancement and spreading the benefits among local communities fairly, as Gabriel Di Blasi of Di Blasi, Parente & Associados and Eduardo Emrich of Biominas Brasil explain.

Working together wisely

International12-10-2016Oliver Laing and Tony Proctor

In a world where research projects are increasingly carried out by several parties in different countries, companies should consider a number of IP-related issues before embarking on multiterritorial collaborations, say Oliver Laing and Tony Proctor of Potter Clarkson.

Boom and boom in the People’s Republic


Over the past few years China’s life sciences sector has become a hive of activity as specialist IP courts have been implemented and M&A activity has ramped up. LSIPR assesses some of these developments.

Francis Crick Institute: a new centre of excellence


In September 2016, the Francis Crick Institute opened the doors to its multimillion-pound new home in London. With a wide range of research being undertaken, LSIPR examines the role of IP and the associated challenges for the organisation.

A woolly debate: the rights and wrongs of cloning

EU, UK10-10-2016

Dolly the Sheep, which would have been 20 this year, raised the possibility of cloning and forced politicians and IP practitioners to address the ethics of the process, with differing results in the US and the UK, as LSIPR reports.

Event preview: Life Sciences Patents Network Europe 2016


On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points.

Showing 111 to 120 of 273 results